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Nerve growth factor (NGF) is a potent survival and axon growth factor for neuronal populations in the peripheral nervous system.
Although themechanismsbywhich target-derivedNGF influences survival of innervatingneuronshavebeen extensively investigated, its
regulation of axonal growth and target innervation are just being elucidated. Here, we identify Wnt5a, a member of the Wnt family of
secreted growth factors, as a key downstream effector of NGF in mediating axonal branching and growth in developing sympathetic
neurons. Wnt5a is robustly expressed in sympathetic neurons when their axons are innervating NGF-expressing targets. NGF:TrkA
signaling enhances neuronal expression of Wnt5a. Wnt5a rapidly induces axon branching while it has a long-term effect on promoting
axon extension. Loss of Wnt5a function revealed that it is necessary for NGF-dependent axonal branching and growth, but not survival,
in vitro. Furthermore, Wnt5a/ mice display reduced innervation of NGF-expressing target tissues, and a subsequent increase in
neuronal apoptosis, in vivo.Wnt5a functions indeveloping sympatheticneuronsby locally activatingproteinkinaseC inaxons.Together,
our findings define a novel regulatory pathway in which Wnt5a, expressed in sympathetic neurons in response to target-derived NGF,
regulates innervation of peripheral targets.
Introduction
To form functional connections during neuronal development,
neurons send out axonal projections that navigate through a se-
ries of intermediate targets to reach their final target tissues. Axon
growth en route to targets encompasses elongation, fasciculation/
defasciculation, changes in axon caliber, interstitial branching to
make connections with intermediate targets, and extensive ter-
minal branching to innervate final target fields (Rubin, 1985).
This latter feature of developing axons is critical for synapse for-
mation and establishment of functional neuronal circuits.
Target-derived growth factors are known to influence the density
of target innervation (Edwards et al., 1989; Diamond et al., 1992;
Causing et al., 1997). However, the precise signalingmechanisms
by which target-derived trophic factors regulate axonal arboriza-
tion and innervation of final target fields are poorly understood.
The neurotrophin, nerve growth factor (NGF), is a target-
derived signal that regulates terminal arborization in developing
sympathetic and sensory neurons in the peripheral nervous sys-
tem (Patel et al., 2000; Glebova and Ginty, 2004; Kuruvilla et al.,
2004;). Overexpression of NGF in target tissues enhanced growth
of sympathetic and sensory nerves into the targets (Edwards et al.,
1989; Albers et al., 1994; Hassankhani et al., 1995). Conversely,
sympathetic and sensory innervation of final target fields is either
absent or incomplete inmice lackingNGFor its cognate receptor,
TrkA (Patel et al., 2000; Glebova andGinty, 2004; Kuruvilla et al.,
2004). Interestingly, the initial phases of axonal outgrowth from
peripheral ganglia and extension along intermediate targets seem
to be NGF independent (Fagan et al., 1996; Glebova and Ginty,
2004; Wickramasinghe et al., 2008). These studies suggest that
target-derived NGF is critical for axonal extension and arboriza-
tion only after the axons have reached their final destinations.
NGF promotes a wide spectrum of actions on peripheral axons in
vitro including elongation, increases in caliber, branching,
growth cone turning responses, and changes in growth conemor-
phology (Gallo and Letourneau, 1998; Markus et al., 2002), all of
which may be required for NGF-mediated innervation of final
target tissues in vivo.
In addition to target-derivedNGF, recent studies indicate that
Wnts secreted by target tissues act as potent axonal branching
and synaptogenic factors to influence target innervation (Ciani
and Salinas, 2005). Wnt7a expressed by cerebellar granule cells
induces growth cone enlargement and axonal spreading of pre-
synaptic mossy fibers (Lucas and Salinas, 1997; Hall et al., 2000).
Wnt3 secreted by motoneurons regulates axonal branching and
terminal arborization ofNT-3-responsive spinal sensory neurons
(Krylova et al., 2002).
Here, we present evidence that NGF promotes axonal branch-
ing and target innervation in developing sympathetic targets by
regulating the neuronal expression of Wnt5a. Wnt5a is most ro-
bustly expressed at a developmental time when axons are reach-
ing final targets. NGF stimulation of sympathetic neurons en-
hanced levels of Wnt5a transcript and protein. Wnt5a had an
acute effect on inducing axonal branching and a long-term effect
on enhancing axon extension. Sympathetic neurons derived
Received March 26, 2009; accepted May 6, 2009.
This work was supported with funds from National Institutes of Health Grant R01 MH080738 and a Whitehall
Foundation award (R.K.). We thank Andreas Kispert for providing the Wnt5a expression vector, Chen-ming Fan for
the dominant-negative TCF adenovirus, and David Ginty for the TrkA F592A mice and 1NMPP1. We are grateful to
Haiqing Zhao, Samer Hattar, andmembers of the Kuruvilla Laboratory for comments on thismanuscript and helpful
discussions.
*D.B. and S.L.-W. contributed equally to this work.
Correspondence should be addressed to Rejji Kuruvilla, Department of Biology, The Johns Hopkins University,
Baltimore, MD 21218. E-mail: rkuruvilla@jhu.edu.
DOI:10.1523/JNEUROSCI.1445-09.2009
Copyright © 2009 Society for Neuroscience 0270-6474/09/297569-13$15.00/0
The Journal of Neuroscience, June 10, 2009 • 29(23):7569–7581 • 7569
from Wnt5a-null mice show deficits in NGF-dependent axonal
branching and growth, but not survival, in vitro. Analysis of
Wnt5a/mice revealed abnormalities in sympathetic chain for-
mation and reduced innervation of target tissues, which lead to
enhanced cell death later in development. Wnt5a functions in
sympathetic neurons by activating a signaling pathway that is
independent of transcription and requires protein kinase C
(PKC) locally in axons. Thus, interactions between Wnt5a ex-
pressed in sympathetic neurons and NGF secreted by neuronal
targets regulate growth events required for innervation.
Materials andMethods
Transgenic animals. Wnt5a/ and TOPGAL reporter mice were ob-
tained from The Jackson Laboratory. The generation of TrkAF592A mice
has been previously described (Chen et al., 2005). All procedures relating
to animal care and treatment conformed to institutional and National
Institutes of Health guidelines.
In situ hybridization. In situ hybridization was done using digoxigenin
(DIG)-labeled cRNA probe specific for mouse Wnt5a. The probe was
generated from a pGEM-7zf() plasmid containing a 2.5 kb insert with
the entire coding region of mouseWnt5a. Embryos were fixed overnight
in 4% paraformaldehyde (PFA) (in 0.1 M PBS), whereas postnatal pups
were transcardially perfused with 4% PFA and postfixed overnight at
4°C. After cryoprotection overnight with 20% sucrose (in PBS) and em-
bedding in OCT (Tissue-Tek), serial cryostat sections (14 m) were
prepared and mounted on SuperFrost Plus slides (Thermo Fisher Scien-
tific). Tissue sections were permeabilized with 0.1% Triton X-100 (in 0.1
M PBS) for 15 min at room temperature and then acetylated with 0.25%
acetic anhydride in 0.1 M triethanolamine with 0.9%NaCl. Sections were
hybridized overnight with labeled RNA probe (1g/ml) at 65°C, washed
in 2 SSC buffer at 60°C, blocked with TBS containing 1% blocking
reagent (Roche), and then incubated with alkaline phosphatase-labeled
anti-DIG antibody (1:3000; Roche) overnight. Sections were washed and
the alkaline phosphatase reaction visualized with NBT/BCIP (nitroblue
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate) (Roche) followed
by rinsing in PBS, fixation in 4% PFA, and mounting the slides using
VectaMount AQ (Vector Laboratories).
Immunohistochemical analyses. Tissue sections (16m)were rinsed in
PBS followed by a 15 min fixation in ice-cold 4% paraformaldehyde in
PBS. Sections were then permeabilized in 1% Triton X-100 in PBS for 15
min, followed by blocking (0.5% Triton X–PBS, 5% goat serum; 1 h) at
room temperature. For immunofluorescence, mouse anti-tyrosine hy-
droxylase (TH-16 ascites; 1:100; Sigma-Aldrich) was applied to sections
overnight at 4°C in a dark, humidified chamber. Sections were then
incubatedwithAlexa 488-conjugated antibody tomouse IgG(1) (1:200;
Invitrogen). Sections were then washed and mounted in Vectashield
(Vector Laboratories). For colorimetric readout, rabbit anti-TH (1:200;
Millipore Bioscience Research Reagents) was applied to sections over-
night at 4°C, washed, incubated with HRP conjugated to rabbit IgG
(1:500; GE Healthcare), and immunoreactivity was detected with diami-
nobenzidine (Sigma-Aldrich).Whole-mount TH immunostaining to vi-
sualize sympathetic chains and axons was performed in embryonic day
16.5 (E16.5)mouse embryos as described previously (Glebova andGinty,
2004). For -galactosidase histochemistry, tissue sections (10 m) were
incubated overnight at room temperature in freshly prepared X-gal
staining solution (2mMMgCl2, 0.01% sodiumdeoxycholate, 0.02% IGE-
PAL, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1
mg/ml X-gal). After X-gal staining, sections were rinsed in PBS and fixed
for 10 min in 4% PFA–PBS. Sections were then counterstained with
Nuclear Fast Red (Vector Laboratories) for 3–5 min. Counterstain reac-
tion was stopped with 10 min treatment of 70% ethanol, and sections
were mounted on slides with 100% glycerol.
Neuronal cell counts.Neuronal cell counts in SCGs were performed as
previously described (Chen et al., 2005). Heads of E13.5, E15.5, E17.5,
and postnatal day 0.5 (P0.5) mice were fixed in PBS containing 4% PFA,
and then cryoprotected in 30% sucrose–PBS, overnight. SCG sections
(10 m) were stained with a solution containing 0.5% cresyl violet
(Nissl). Cells with characteristic neuronal morphology and visible nucle-
oli were counted in every fifthNissl stained section. For E13.5, E15.5, and
E17.5 embryos, sections were also stained for TH, and immunopositive
cells were counted in every fifth section.
PCR analyses. For real-time quantitative PCR (qPCR) analyses, total
RNA was prepared from mouse sympathetic neuron cultures using the
RNeasy Micro Kit (QIAGEN). Poly(A) RNAs were reverse transcribed
using RETROscript kit (Ambion). Real-time qPCR was performed with
iQ SYBRGreen Supermix and iCycler iQ real-time PCRdetection system
(Bio-Rad). Each sample was analyzed in four replicate reactions of 50l.
Immunocytochemistry, immunoblotting, and antibodies. Cells were
fixed with 4% PFA in PBS, blocked with 3% BSA in PBS, and immuno-
stained overnight with primary antibodies against Wnt5a (1:1000; Neu-
romics or R&D Systems) or -III-tubulin (1:500; Sigma-Aldrich). Im-
ages were acquired using either confocal microscopy (Zeiss LSM510
Meta confocal microscope) or epifluorescence microscopy (Zeiss Axio-
plan microscope). After washing, neurons were incubated with appro-
priate secondary antibodies (Alexa Fluor; Invitrogen). Immunoblotting
analyses of sympathetic neuron lysates were performed as described pre-
viously (Kuruvilla et al., 2004). For NGF-dependent regulation ofWnt5a
protein, sympathetic neurons were grown for 4–5 d in vitro in the pres-
ence of NGF (50 ng/ml) and AraC (10 M), and then starved of NGF in
the presence of boc-aspartyl(OMe)-fluoromethylketone (BAF) for 2 d
and then stimulatedwithNGF (50 ng/ml) for different time points before
being harvested for Wnt5a immunoblotting. For sympathetic neurons
from TrkAF592Amice, SCG neurons from P0.5mice were cultured in the
presence of NGF (50 ng/ml) and AraC (10 M) for 4–5 d in vitro, then
treated with 4-amino-1-tert-butyl-3-(1-naphthylmethyl)pyrazolo[3,4-
d]pyrimidine (1NMPP1) (100 nM; 12 h), and lysates harvested forWnt5a
immunoblotting. The following antibodies were used for immunoblot-
ting: Wnt5a (R&D Systems), -tubulin (Sigma-Aldrich), and p85 sub-
unit of PI-3 kinase (Millipore). All phosphospecific antibodies including
p-PKC (pan,II Ser660), p-c-Jun (Ser63), p-calcium–calmodulin kinase
II (p-CaMKII) (Thr286), p-GSK-3 (Ser9), p-Akt (Ser473), and
p-Erk1/2 (Thr202/Tyr204) were obtained from Cell Signaling
Technology.
Neuronal cultures and quantification of neurite length, axon branching,
and neuronal survival. SCGs, dissected from wild-type and Wnt5a/
embryos (E18.5) obtained fromWnt5a heterozygous mothers, were cul-
tured in collagen gel in media containing NGF (50 ng/ml) for 72 h, and
then immunostained with -III-tubulin. For rescue experiments with
exogenousWnt5a, E16.5Wnt5a/ SCG explants were grown for 72 h in
collagen gel in control or Wnt5a conditioned media supplemented with
NGF (50 ng/ml), and then immunostained for -III-tubulin. Neurite
outgrowth in SCG explants was quantified bymeasuring the area covered
by the axons of each explant relative to the area occupied by the cell
bodies. Low-density cultures were established from P0.5 rat pups or
E18.5 wild-type and Wnt5a/ embryos and cultured on polylysine/
laminin-coated coverslips (for 8 or 24 h as indicated in the figure leg-
ends). To visualize neuronal morphology in fixed cells, neurons were
stained with -III-tubulin antibody. To measure neurite length and ax-
onal branching of isolated sympathetic neurons, random neurons (at
least 50 clearly separated neurons selected per dish) were imaged using a
Zeiss Axiovision microscope with a AxioCam HRC digital camera and
analyzed with Axiovision software. Length (in micrometers) of the long-
est neurite as well as the total number of branch points were quantified
for each neuron. Neurites longer than 5 m were counted as branches.
To determine the effects of exogenous Wnt5a on sympathetic neuron
survival, dissociated neurons from P0.5 rat pups were cultured in the
presence of NGF (10 ng/ml) for 4–5 d in vitro to allow elaboration of a
dense network of axons. Neurons were then washed to remove NGF and
cultured for another 2 d in Wnt5a or control conditioned media in the
presence or absence ofNGF (10 ng/ml). Cultures grown in the absence of
NGF were treated with a neutralizing antibody to NGF (anti-NGF;
1:1000; Sigma-Aldrich) to ensure complete removal of NGF from the
culture media. To assess the ability of wild-type andWnt5a/ neurons
to survive in the presence of NGF, sympathetic neurons harvested from
E15.5 wild-type andWnt5a/ embryos were cultured for 4–5 d in vitro
in different concentrations of NGF (1, 10, and 30 ng/ml)-containing
media and then stained with the nuclear dye, Hoechst 33258 (Invitro-
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gen). Neurons with pyknotic, condensed, or fragmented nuclei were
scored as dead.
To block transcription, neurons were plated and cultured for 8 h in
control conditioned medium and then treated with control or Wnt5a
conditioned medium in the presence or absence of actinomycin D
(0.1 g/ml) for 16 h. Longer incubations with actinomycin D resulted
in cytotoxic effects. To block translation, neurons were cultured over-
night in control conditioned medium, pretreated with cycloheximide
(1 g/ml) or vehicle (DMSO) for 15 min, and then treated with
control or Wnt5a conditioned medium in the presence or absence of
cycloheximide (1 g/ml) for 1 h. To investigate the requirement of
PKC in Wnt5a-dependent axonal branching, neurons were cultured
in control or Wnt5a conditioned media in the presence or absence of
myristoylated PKC pseudosubstrate (25 M; catalog #P-205; BI-
OMOL) for 24 h.
Live imaging. Sympathetic neurons cultured for 8 h in control condi-
tioned media were treated with control or Wnt5a conditioned medium,
and images taken at 30 min intervals for up to 2 h. Neurons were viewed
with a 20/0.4 Neofluar phase contrast objective attached to a Zeiss
Axiovert microscope, and images were taken with a Retiga Exi digital
camera with Openlab software (Improvision).
Axonal extension and branching in compartmentalized cultures. Com-
partmentalized cultures of sympathetic neurons from P0.5 rat pups were
set up, and axonal elongation (in micrometers per day) was measured as
described previously (Ye et al., 2003). Compartmentalized cultures were
initially maintained in NGF-containing media for 5–7 d to allow robust
axonal growth into axonal compartments. To analyze Wnt-mediated
effects alone, NGF was withdrawn from the culture media bathing cell
bodies and axons on addition of either control orWnt5amedia to axonal
compartments. Distal axon compartments were photographed every
24 h for the next 3 d using a Zeiss Axiovert microscope equipped with a
Retiga EXi camera. Axon length was measured using Openlab software
(Improvision) and expressed as average axon growth per day (in mi-
crometers per day). For axon branching, low-density sympathetic cul-
tures in compartmentalized chambers were established to allow visual-
ization of “single” axons projecting into side compartments. In all axon
growth and branching assays, the caspase inhibitor BAF (50 M) was
added to cultured neurons to prevent cell death in absence of NGF. In
experiments neutralizing Wnt5a, axons in compartmentalized cultures
were treated withmedia containing anti-NGF (1:1000), NGF (50 ng/ml),
orNGF (50 ng/ml) plus anti-Wnt5a (5g/ml) for 72 h. For axons treated
with anti-NGF or NGF alone, goat IgG (5 g/ml) was included in the
media as a control. In all experimental conditions, cell bodies weremain-
tained inmedia containing anti-NGF. Neurons were fixed and immuno-
stained for -III-tubulin (1:200 dilution; Sigma-Aldrich). Axonal
branching was measured by photographing axonal compartments using
a Zeiss Axiovert microscope equipped with a Retiga EXi camera, and
counting the total number of axonal branch points for all axons per
collagen track. For every axon, each point of divergence from the main
axonal shaft was counted as a branch point. For axonal branching assays
involving PKC pseudosubstrate, compartmentalized cultures were
treated with control or Wnt5a-containing media on distal axons in the
presence or absence of PKC pseudosubstrate (25 M) on cell bodies or
distal axons. Quantification of axonal branch points was performed by
photographing axons at 0 and 24 h after treatment and counting the
number of new branch points formed per projection.
Statistical analyses. Statistical comparisons were determined by the
Student’s t test for pair comparisons and by one-way ANOVA for mul-
tiple comparisons. Post hoc analyses were done using Tukey–Kramer’s
test. Values and error bars indicate mean SEM.
Results
NGF regulatesWnt5a expression in sympathetic neurons
Levels of Wnt5a transcript, as detected by in situ hybridization,
are low in the primordial SCG at E13.5 (Fig. 1A), a developmen-
tal stage when the SCG is coalescing into a discrete ganglion.
Robust expression of Wnt5a in the SCG was observed at E16.5
(Fig. 1B) and P0.5 (Fig. 1C), when there is peak innervation of
sympathetic targets. Sense control showed little staining indicat-
ing the specificity of the in situ probe (supplemental Fig. 1A,B,
available at www.jneurosci.org as supplemental material). By
P14.5 (Fig. 1D) and in the adult SCG at P40.5 (Fig. 1E), Wnt5a
expression is restricted to a subpopulation of neurons. Immuno-
cytochemical analyses in dissociated SCG cultures showed that
the Wnt5a protein is localized primarily to sympathetic neurons
and not residual glial cells (supplemental Fig. 1C,D, available at
www.jneurosci.org as supplemental material). Together, these
results indicate thatWnt5a expression in developing sympathetic
neurons is synchronous with the timing of target field
innervation.
Given the prominent expression of Wnt5a in sympathetic
neurons at developmental times when sympathetic axons are be-
ing exposed to target-derived NGF in vivo, we asked whether
NGF regulates Wnt5a expression. Sympathetic neurons isolated
from mouse P0.5 SCGs were cultured for 12, 24, and 48 h in the
presence or absence of NGF. The broad-spectrum caspase inhib-
itor BAF was added to the cell cultures to circumvent neuronal
apoptosis in the absence of NGF. Wnt5a transcript levels were
assayed by quantitative real-time PCR analyses. NGF treatment
significantly enhanced Wnt5a mRNA levels in cultured sympa-
thetic neurons at all three time points examined (Fig. 1F) (12 h,
p  0.0068; 24 h, p  0.0075; and 48 h, p  0.0412, two-tailed
Student’s t test), whereas expression of Wnt4 and Wnt11 were
unaffected by NGF (supplemental Fig. 2A, available at
www.jneurosci.org as supplemental material). We also cultured
sympathetic neurons for 5 d in vitro in the continued presence of
NGF (50 ng/ml) to allow the formation of a dense network of
axons, after which the neurons were starved for 2 d in the pres-
ence of BAF, and then either left untreated or stimulated with
NGF (50 ng/ml) for 12 h.We observed a similar twofold elevation
of Wnt5a transcript levels with NGF treatment (supplemental
Fig. 2B, available atwww.jneurosci.org as supplementalmaterial)
as seen in Figure 1F, providing more definitive evidence that
upregulation of Wnt5a is the result of NGF stimulation rather
than being secondary to a global trophic effect of NGF. In addi-
tion, Wnt5a levels were not influenced by treatment of sympa-
thetic neurons with NT-3 (Fig. 1G), a neurotrophin highly ex-
pressed in blood vessels along the trajectory of sympathetic axons
(Francis et al., 1999) and that promotes robust neurite outgrowth
by activating TrkA receptors (Belliveau et al., 1997; Kuruvilla et
al., 2004). NGF treatment also increased amounts of Wnt5a pro-
tein in cultured sympathetic neurons (Fig. 1H).
To further address the role of NGF in regulating Wnt5a ex-
pression, we used TrkAF592A mice, a knock-in mouse line ex-
pressing the NGF receptor, TrkA, with a mutated ATP binding
pocket (Chen et al., 2005). With this modification, TrkA recep-
tors can be selectively and reversibly inhibited by the small-
molecule membrane-permeable inhibitor 1NMPP1 (Chen et al.,
2005). In sympathetic neuron cultures established from
TrkAF592A mice, we found that inhibition of TrkA kinase activity
with 1NMPP1 substantially attenuated Wnt5a levels in neurons
maintained in the presence ofNGF (Fig. 1 I) (percentage decrease
of 35 5.6%; p 0.0038, paired, two-tailed Student’s t test; n
4 independent experiments). 1NMPP1 had no effect on Wnt5a
expression in neurons expressing wild-type unmodified TrkA re-
ceptors (supplemental Fig. 3, available at www.jneurosci.org as
supplementalmaterial). These results suggest thatWnt5a expres-
sion in sympathetic neurons is dependent on NGF:TrkA
signaling.
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Wnt5a promotes axon branching in developing
sympathetic neurons
Given that NGF regulates Wnt5a expression, we asked whether
Wnt5a treatment of sympathetic neuronswould elicit effects sim-
ilar to those ascribed to NGF such as axon growth and survival.
To test a possible role for Wnt5a in sympathetic axonal growth
and morphology, we grew low-density cultures of dissociated
sympathetic neurons in conditioned medium obtained from
Wnt5a-expressing fibroblasts (supplemental Fig. 4, available at
www.jneurosci.org as supplemental material) in the presence or
absence of NGF. As controls, cultures were grown in conditioned
media obtained from the parental fibroblasts used to generate the
Wnt5a-expressing cell line. Cells grown in the absence of NGF
were treated with BAF to prevent apoptosis. Neuronal morphol-
ogy was assessed by -III-tubulin immunostaining 8 and 24 h
after plating cells. At 8 h, Wnt5a elicited substantial axonal
branching (Fig. 2B). Control medium-treated neurons averaged
4.29  0.517 branches per neuron (mean  SEM). In the pres-
ence of Wnt5a, axon branching increased almost threefold to
12.708  0.755 (Fig. 2E) ( p  0.001, one-way ANOVA with
Tukey–Kramer’s post hoc test). Neurite length was comparable
between control and Wnt5a-treated neurons, 160.8  7.4 and
188  6.11 m, respectively (Fig. 2F) ( p  0.05, one-way
ANOVA with Tukey–Kramer’s post hoc test). In contrast to
Wnt5a, treatment with NGF for 8 h (Fig. 2C) had no significant
effect on axon branching (Fig. 2E) but caused a substantial in-
crease in neurite length (Fig. 2F) ( p  0.05, one-way ANOVA
with Tukey–Kramer’s post hoc test). Over a 24 h period, NGF-
treated neurons (Fig. 2 I) exhibited the elaborate branching mor-
phologies seen in Wnt5a-treated neurons (Fig. 2H) with
23.002  2.507 and 22.616  1.031 branch points per neuron,
respectively (Fig. 2K), although NGF-treated neurons were sig-
nificantly longer than control- and Wnt5a-treated neurons (Fig.
2L) (control neurons, 263  21.7 m; Wnt5a-treated neurons,
316 10.6m; NGF-treated neurons, 380 17.2m; p 0.05,
one-way ANOVA with Tukey–Kramer’s post hoc test). Thus,
whereas the effects of Wnt5a on axonal branching are observed
within 8 h, NGF-induced axonal arborization is observed only
after 24 h. The effect of NGF on axonal branching is similar to,
but not additive with, Wnt5a, since addition of NGF to Wnt5a-
treated neurons did not further augment axonal arborization
(Figs. 2E,K). At 24 h, there were no significant differences in
neurite length between control andWnt5a-treated neurons (Fig.
2L) indicating a specific effect of Wnt5a on axonal branching.
To test a possible role forWnt5a in neuronal survival, we grew
low-density cultures of dissociated sympathetic neurons in
Figure 1. NGF:TrkA signaling regulates Wnt5a expression in developing sympathetic neurons. A–E, In situ hybridization analyses show expression ofWnt5a in the developing SCG. The SCG is
outlined indashed lines inA; the asterisk (*) identifies aneighboringbloodvessel. Scale bar, 200m.F,G, Real-timePCRanalyses showan increase inWnt5a transcript levels in sympathetic neurons
cultured for 12, 24, and 48h, in the presence of NGF (100ng/ml) (F ), but notNT-3 (100ng/ml) (G). For each timepoint,Wnt5a levels in neurotrophin-treated cultureswere comparedwith untreated
control cultures grown in the absence of growth factor and kept viable with BAF. No changes inWnt5a levels were observed in control cultures over the course of the experiment. Values are the
mean SEM from six independent experiments. For NGF-treated cultures, 12 h, **p 0.0068; 24 h, **p 0.0075; 48 h, *p 0.0412; for NT-3-treated cultures, 12 h, p 0.5657; 24 h, p
0.8411; 48h,p0.2085, as determinedbya two-tailed Student’s t test.H, NGF treatment increasesWnt5aprotein levels in cultured sympathetic neurons asdeterminedby immunoblotting.Wnt5a
immunoblots were stripped and reprobed with anti--tubulin as a loading control. I, Inhibition of TrkA kinase activity with the small molecule inhibitor 1NMPP1 (100 nM; 12 h) reduces Wnt5a
protein levels in TrkA F592A sympathetic neurons grown in the presence of NGF. The Wnt5a blot was stripped and reprobed for the p85 subunit of PI3-K (phosphatidylinositol 3-kinase) for
normalization. The Wnt5a antibody recognizes a doublet of	45 kDa (white arrowheads) and 40 kDa (black arrowheads).
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Wnt5a or control conditioned medium in the presence or ab-
sence of NGF for 48 h. Percentage neuronal survival was deter-
mined by Hoechst staining to visualize nuclear morphology.
Wnt5a treatment did not promote neuronal survival, with only
34% of neurons surviving, comparable with the 29% survival
observed when neurons were cultured in the absence of NGF. In
contrast, treatment of neurons with NGF (10 ng/ml), in the pres-
ence or absence ofWnt5a, supported neuronal survival at	85%
(Fig. 2M). These results indicate that Wnt5a is not sufficient to
promote sympathetic neuron survival in the absence of NGF.
Wnt5a-mediated axon branching is rapid and
transcription independent
To visualize how sympathetic axons develop in response to
Wnt5a, we performed time-lapse imaging ofWnt5a-treated neu-
rons at 30 min intervals for up to 2 h. Neurons were initially
plated and cultured in control conditioned medium for 8 h, and
then stimulated with Wnt5a media. Wnt5a had immediate and
pronounced effects on axon branching. As early as 30 min after
Wnt5a addition, neurons exhibited distinct sprouting and exten-
sion of branches (Fig. 3G,K), and after 2 h of imaging, most
Wnt5a-treated neurons had elaborate multibranched arbors
(Fig. 3J). The number of newly formed branches increased with
time such that Wnt5a-treated neurons (n  16 neurons) aver-
aged 18.64  2.1 branches per neuron after 2 h of imaging, an
increase of 188% (Fig. 3F–K). In neurons treated with control
conditioned medium (n  18 neurons), the rate and extent of
branching was slow, averaging 9.88 0.55 branches per neuron
after 2 h (Fig. 3A–E,K). Although the newly formed branches in
Wnt5a-treated neurons showed rapid extension, the primary
neurites grew to a similar extent as in control medium-treated
neurons, such that we observed no obvious differences in length
of the longest neurite between the two groups after 2 h.
These rapid effects indicate that Wnt5a might induce axon
remodeling by regulating cytoskeletal effectors, independent of
transcription. To directly test the role of transcription in the ac-
tion ofWnt5a, neuronswere first cultured in control conditioned
medium for 8 h to allow neurite outgrowth and then exposed to
Wnt5a in the presence of the transcription inhibitor actinomycin
D (0.1 g/ml) for 16 h. This concentration of actinomycin D has
been shown previously to completely block transcription in sym-
pathetic neuron cultures (Franklin and Johnson, 1998). Actino-
mycin D had no effect on Wnt5a-induced axon branching (Fig.
3L), indicating a transcription-independent mode of action for
Wnt5a. To test the translational requirements for the rapid effects
of Wnt5a on axon branching, we initially cultured neurons over-
night in control conditionedmedium to allow formation of neu-
rites. Subsequently, we treated cultures with control or Wnt5a-
Figure 2. Wnt5a promotes axonal branching and growth. A–D,-III-Tubulin staining showsmorphologies of sympathetic neurons cultured for 8 h in control media (A), Wnt5a (B), NGF (C), or
NGF plusWnt5a (D)-containingmedia. Scale bar, 50m. E, F, Quantification of branch points per neuron (E) and neurite length (F ) in low-density dissociated cultures treated as described inA–D.
Values are themean SEM from five independent experiments. *p 0.05, **p 0.01, and ***p 0.001, significantly different from controlmedia-treated neurons, as determined by one-way
ANOVA followed by Tukey’s multiple-comparisons test. G–J,-III-Tubulin staining showsmorphologies of sympathetic neurons cultured for 24 h in control media (G), Wnt5a (H ), NGF (I ), or NGF
plusWnt5a (J )-containingmedia. Scale bar, 50m.K, L, Quantification of branchpoints per neuron (K ) andneurite length (L) in low-density dissociated cultures treated as described inG–J. Values
are themean SEM from five independent experiments. *p 0.05 and ***p 0.001, significantly different from control medium-treated neurons, as determined by one-way ANOVA followed
byTukey’smultiple-comparisons test.M, Quantificationof percentageneuronal survival in dissociated cultures treatedwith anti-NGF, anti-NGFplusWnt5a,NGF, orNGFplusWnt5a for 48h.Neurons
were initially grown for 4–5 d in NGF (10 ng/ml)-containingmedia and then shifted to the different conditions described above. Neuronal survival was determined by Hoechst staining to visualize
nuclear morphology. Values are the mean SEM from four independent experiments. ***p 0.001, significantly different from anti-NGF-treated neurons, as determined by one-way ANOVA
followed by Tukey’s multiple-comparisons test.
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containing media for 1 h in the presence or absence of the
translational inhibitor cycloheximide (1g/ml; pretreatment, 15
min). Cycloheximide treatment did not affect the ability of
Wnt5a to induce short-term axon branching (Fig. 3M), suggest-
ing a translation-independent mechanism potentially via local
regulation of cytoplasmic effectors. Together, these experiments
demonstrate a potent, rapid, and transcription/translation-
independent effect of Wnt5a on the rate and extent of axon
branching in developing sympathetic neurons.
Localized effects ofWnt5a on axon branching and growth
To determine whether Wnt5a could locally induce changes in
axonmorphology and growth,Wnt5a was added directly to axon
terminals of compartmentalized cultures of sympathetic neu-
rons. In this culture system, neuronal cell bodies and axon termi-
nals are segregated into distinct fluid compartments by a Teflon–
grease barrier, allowing addition of growth factors directly to
axons (Campenot, 1977, 1979). Wnt5a-treated axons showed
strikingly elaboratemorphologies with significantly enhanced ar-
borization (Fig. 4B), whereas hardly any branching was seen in
sympathetic axons treated with control media (Fig. 4A). Wnt5a-
treated neurons had on average 16.38  2.99 branch points per
axon compared with 6.69  1.72 branch points per axon for
control neurons ( p  0.0267, unpaired, two-tailed Student’s t
test). The complex pattern of arborization seen inWnt5a-treated
axons in vitro is reminiscent of the morphological changes that
sympathetic axons undergo in vivo on innervation of final target
tissues (Glebova and Ginty, 2004). Wnt5a added exclusively to
axon compartments also significantly enhanced axonal extension
(in micrometers per day) into side compartments of compart-
mentalized cultures over the 72 h period of monitoring axon
growth (Wnt5a, 291.05 32.96m/d, vs control, 172.32 10.78
m/d; p  0.0485, unpaired, two-tailed Student’s t test). Thus,
whereas the effects of Wnt5a on axonal branching are observed
within 8 h, Wnt5a-induced increases in axon elongation are ob-
served after 3 d of exposure to the Wnt ligand.
Figure3. Wnt5a elicits rapid effects on axon branching, independent of transcription and translation.A–E, Phase-contrast images of a sympathetic neuron treatedwith controlmedia for 30min
(B), 60 min (C), 90 min (D), and 120 min (E). F–J, Phase-contrast images of a sympathetic neuron treated with Wnt5a-containing media for 30 min (G), 60 min (H ), 90 min (I ), and 120 min (J ).
Neuronswere initially plated in control conditionedmedium for 8h, and then treatedwithWnt5aor controlmedia for up to2h. Scale bar, 40m.K, Quantificationof axonal branchpoints inneurons
treated as described inA–J. Results are themean SEM froma total of three independent experimentswith six to eight neurons imagedper condition for each experiment. *p 0.05, **p 0.01,
***p 0.001, significantly different from control medium-treated neurons, as determined by one-way ANOVA followed by Tukey’s multiple-comparisons test. L, Quantification of axonal branch
points in neurons treatedwith control orWnt5amedia in the presence or absence of actinomycinD (0.1g/ml). Neuronswere initially plated in control conditionedmedium for 8 h and then treated
withWnt5a or control media in the presence or absence of actinomycin D (0.1g/ml) for 16 h. Neurons were then fixed and immunostainedwith-III-tubulin. **p 0.01, significantly different
from control medium-treated neurons, as determined by one-way ANOVA followed by Tukey’smultiple-comparisons test.M, Quantification of axonal branch points in neurons treatedwith control
or Wnt5amedia in the presence or absence of cycloheximide (1g/ml). Neurons were initially plated in control conditionedmedium overnight to allow extension of neurites, and then treated for
1 h with Wnt5a or control media in the presence or absence of cycloheximide (1g/ml; pretreatment, 15 min). Neurons were then fixed and immunostained with-III-tubulin. *p 0.05 and
**p 0.01, significantly different from control medium-treated neurons, as determined by one-way ANOVA followed by Tukey’s multiple-comparisons test.
7574 • J. Neurosci., June 10, 2009 • 29(23):7569–7581 Bodmer et al. • Neurotrophins andWnts Coordinate Axon Growth
If NGF regulatesWnt5a expression in sympathetic neurons to
mediate axonal growth and branching, then depleting endoge-
nousWnt5a should interferewith the growth-promoting abilities
of NGF. To block endogenousWnt5a signaling, we used an anti-
body that has been previously shown to neutralizeWnt5a activity
in hematopoietic stem cells (Murdoch et al., 2003). In compart-
mentalized cultures, NGF added exclusively to axon terminals of
sympathetic axons elicits axonal extension
and branching responses (Fig. 4D). Con-
sistentwith previous studies, the axonal ef-
fects of NGF were completely eliminated
by the inclusion of a neutralizing antibody
to NGF (Fig. 4C) (Kuruvilla et al., 2004).
Sympathetic axons treated with NGF in
the presence of theWnt5a neutralizing an-
tibody were shorter and highly fascicu-
lated, with little branching at their termi-
nals (Fig. 4E). These results suggest that
the Wnt5a synthesized by sympathetic
neurons is secreted and that it acts down-
stream of NGF to mediate axonal exten-
sion and branching. The neutralizing
Wnt5a antibody antagonized NGF-
dependent axonal branching (Fig. 4F) and
growth (Fig. 4G) only when added to distal
axons and had no significant effect when
added directly to cell bodies. Together
with our findings that Wnt5a promotes
branching within minutes and that it acts
via a transcription-independent mecha-
nism (Fig. 3A–L), these results point to a
local effect of Wnt5a in distal axons.
NGF-dependent axonal branching and
growth is reduced in sympathetic
neurons lackingWnt5a
To directly test the role of Wnt5a as a
downstream effector of NGF-dependent
axonal branching, we next analyzed the
ability of neurons lacking Wnt5a to grow
in response to NGF. NGF-dependent ax-
onal growth was assessed in SCG explants
and dissociated sympathetic neurons iso-
lated fromWnt5a/ and wild-type mice.
SCG explants (n 8 explants for each ge-
notype) harvested from E18.5 wild-type
and Wnt5a/ mice were grown for 72 h
in collagen gel in the presence of NGF.
Whereas control explants exhibited robust
NGF-dependent axonal growth as evident
from a broad axonal halo (Fig. 5A),
Wnt5a/ explants showed poor out-
growth (Fig. 5B), despite the presence of
NGF in the culture media. Neurite out-
growth, as quantified by measuring the
area covered by the axons of each explant
relative to the area occupied by the cell
bodies, indicated a significant 1.6-fold re-
duction in growth by Wnt5a/ explants
( p 0.029, unpaired, two-tailed Student’s
t test).
Low-density cultures of dissociated
sympathetic neurons were established
from Wnt5a/ and wild-type mice, and their morphology ex-
amined after 24 h in culture by immunostaining for -III-
tubulin. For the majority of wild-type neurons, a single axonal
shaft emerged from a neuronal cell body, which then ramified
into secondary branches and finer collaterals (Fig. 5C). In wild-
type neurons, the main axonal shaft and secondary branches had
several filopodia-like extensions that were longer than 5 m. In
Figure 4. Localized effects of Wnt5a on axon branching and growth. A, B, Wnt5a added directly to axons promotes axonal
branching andaxonal extensionover 3d. In compartmentalized cultures,Wnt5a-treated axons (B) exhibit robust axonal arboriza-
tion and growth, compared with axons treated with control medium (A). Images of-III-tubulin immunostaining are inverted.
Scale bar, 330m. C–E, NeutralizingWnt5a in axon compartments attenuates NGF-dependent growth. NGF added exclusively to
sympathetic axons in compartmentalized cultures elicits axonal extension and branching responses (D, arrows) that are elimi-
nated by the inclusion of a neutralizing antibody to NGF (C). Sympathetic axons treated with NGF in the presence of a Wnt5a
neutralizing antibodywere shorter and highly fasciculated,with little branching at their terminals (E, arrowheads). Scale bar, 330
m. F, G, Quantification of branch points per track (F ) and axonal growth (in micrometers per day) (G) in low-density compart-
mentalized cultures treated as indicated in C–E except in the last condition in which neutralizing Wnt5a antibody was added to
the cell body (CB) compartments. Values are the mean SEM from six independent experiments. *p 0.05, **p 0.01, and
***p 0.001, as determined by one-way ANOVA followed by Tukey’s multiple-comparisons test.
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contrast, Wnt5a/ neurons had very smooth axons with little
branching along the main axonal shaft and secondary branches
(Fig. 5D). Quantification of axonal branch points indicated a
2.3-fold reduction in axonal branching in Wnt5a/ neurons
(n 7 independent experiments, total of 265 neurons) compared
with wild-type neurons (296 neurons) ( p  0.0004, unpaired,
two-tailed Student’s t test). No significant differences were ob-
served in neurite length between wild-type and mutant neurons
after 24 h in culture ( p 0.0636, unpaired, two-tailed Student’s
t test), indicating that axon outgrowth is less sensitive to the loss
of Wnt5a than axonal branching.
We reasoned that, if the loss ofWnt5a is primarily responsible
for reduced axonal branching observed in Wnt5a/ neurons
cultured in the presence of NGF, addition of exogenous Wnt5a
should rescue the deficits. Indeed, Wnt5a/ SCG explants ex-
posed to exogenousWnt5a for 72 h showed a significant 2.3-fold
increase in axonal outgrowth compared with those treated with
control medium (Fig. 5E,F) (n 3 explants for each condition;
p  0.027, unpaired, two-tailed Student’s t test). Exogenous
Wnt5a also elicited elaborate axonal arborization in dissociated
Wnt5a/ sympathetic neurons, compared with those treated
with control medium (Fig. 5G,H). Quantification revealed a sig-
nificant increase (threefold) in axonal branching ( p  0.016,
unpaired, two-tailed Student’s t test), but not neurite length ( p
0.22, unpaired, two-tailed Student’s t test) inWnt5a/ neurons
treated with exogenous Wnt5a in the 24 h culture period. These
results indicate that the signaling machinery required to respond
to Wnt5a-dependent branching remains intact in Wnt5a/
neurons and that the branching deficits are caused primarily by
the absence of Wnt5a in these neurons.
Wnt5a/mice have deficits in the developing sympathetic
nervous system
Given the axonal branching and growth deficits observed in vitro
in sympathetic neurons lacking Wnt5a, we investigated whether
Wnt5a is required for SCG development and sympathetic inner-
vation of target tissues in vivo. In Wnt5a/ mice, the SCG at
E13.5 had coalesced into discrete ganglia and expressed tyrosine
hydroxylase, a marker of neuronal differentiation (Fig. 6A,B)
and -III-tubulin (data not shown) at normal levels. Further-
more, from E13.5 to E15.5, a time period of robust cellular pro-
liferation (Fagan et al., 1996), the Wnt5a/ SCG has a similar
number of cells compared with wild type, suggesting early stages
of differentiation and proliferation are unperturbed by Wnt5a
loss (Fig. 6A–D,I). However, at E17.5, when sympathetic neuro-
nal survival is dependent on NGF, we observed a substantial
(34%) decrease in Wnt5a/ SCG cell number that progressed
throughout P0.5 (Fig. 6E–I) ( p 0.01 for E17.5 and p 0.05 for
P0.5, unpaired two-tailed Student’s t test), similar to the timing
and magnitude of developmental cell loss documented in
NGF/ (Brennan et al., 1999; Francis et al., 1999) and TrkA/
mice (Fagan et al., 1996). For comparison, in both NGF/ and
TrkA/mice, a significant reduction in neuronal number is first
detected at E17.5, with a 39–61% decrease in the NGF/mice
(Brennan et al., 1999; Francis et al., 1999) and 35% decrease in
TrkA/ mice (Fagan et al., 1996) compared with wild-type
mice.
Given the decrease in SCGcell number at E17.5, we performed
immunocytochemistry against tyrosine hydroxylase and an apo-
ptotic marker, cleaved caspase-3, in the wild-type andWnt5a/
SCG. Quantification of the percentage of caspase-3-positive cells
in E15.5 wild-type (6.8  1.6%) and Wnt5a/ (7.4  2.5%)
SCG indicated there is no significant difference in levels of apo-
Figure 5. Sympathetic neurons lacking Wnt5a show deficits in NGF-dependent axonal
branching and growth. A, B, Reduced NGF-dependent axonal growth in SCG explants from
Wnt5a/mice. SCG explants from E18.5wild-type (A) andWnt5a/ (B)micewere grown
for 3 d in collagengel inNGF-containingmedia; gangliawere then fixed and immunostained for
-III-tubulin. Scale bar, 320m.C,D,Wnt5a/ sympathetic neurons show reducedbranch-
ing in response to NGF. Dissociated sympathetic neurons isolated from E18.5 wild-type (C) or
Wnt5a/ (D) embryos were cultured for 24 h in NGF-containing media and then immuno-
stained for-III-tubulin. Scale bar, 20m. E, F, Exogenous Wnt5a rescues the axonal growth
deficits inWnt5a/ SCG explants. SCG explants from E16.5Wnt5a/micewere grown for
3 d in collagen gel in control (E) or Wnt5a (F ) conditioned media supplemented with NGF (50
ng/ml), and then immunostained for-III-tubulin. Scale bar, 320m.G,H, ExogenousWnt5a
rescues thebranchingdeficits indissociatedWnt5a/neurons.Dissociated sympathetic neu-
rons isolated from E18.5 Wnt5a/mice were cultured for 24 h in control (G) or Wnt5a (H )
conditioned medium supplemented with NGF (50 ng/ml), and then immunostained for-III-
tubulin. Scale bar, 40m.
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ptosis at E15.5 (Fig. 6 J,K,N). In contrast, at E17.5, the percentage
of cleaved caspase-3-positive cells is significantly higher in the
Wnt5a/ SCG (22.9 4.3%) compared with wild type (12.5
1.2%) (Fig. 6L–N). Thus, enhanced SCG apoptosis and reduc-
tion in cell number inWnt5a/ embryos
occurs at a developmental time when ax-
ons are actively innervating target tissues
and gaining access to NGF.
To determine whether there is a cell-
autonomous requirement for Wnt5a in
neuronal survival, we isolated sympathetic
neurons from wild-type and Wnt5a/
SCGs at E15.5, before the onset of en-
hanced apoptosis seen in vivo, and main-
tained dissociated neurons in different
concentrations of NGF (1, 10, and 30 ng/
ml) for 4 d in vitro. Although NGF at 10
and 30 ng/ml was more effective than 1
ng/ml at promoting neuronal survival in
both wild-type and Wnt5a/ neurons,
we did not see any significant differences
in sensitivity to NGF between the two ge-
notypes. Quantification of NGF-
dependent neuronal survival showed
equivalent numbers of surviving
Wnt5a/ and wild-type neurons at each
NGF concentration (Fig. 6O). These re-
sults indicate that Wnt5a is not primarily
required to mediate NGF-dependent neu-
ronal survival.
In light of the requirement for Wnt5a
in NGF-mediated axon branching in vitro
and the increased apoptosis in Wnt5a/
SCG when neuronal survival is dependent
on target-derived NGF, we examined in-
nervation of distal sympathetic targets in
Wnt5a/ mice. TH staining of SCG tar-
gets indicated far less sympathetic fibers
innervate the nasal epithelium at E15.5
(Fig. 6P,Q) and the eye at E16.5 (Fig.
6R,S) in Wnt5a/ embryos compared
with wild type. These results indicate that
Wnt5a/ sympathetic fibers fail to effec-
tively innervate distal targets, before ob-
served increases in neuronal apoptosis and
cell loss at E17.5.
Because of the shortened anterior–pos-
terior axis in Wnt5a/ embryos, we in-
vestigated the spatial organization of the
entire sympathetic chain. By whole-
mount tyrosine hydroxylase staining, we
determined that E16.5Wnt5a/ embryos
had aberrant segmentation and organiza-
tion of the sympathetic chain that was
more pronounced caudally (Fig. 6U, black
arrowheads). These defects in segmenta-
tion were also observed in the nascent
sympathetic chain at E13.5 (data not
shown). Although we sometimes observed
axonal projections emanating from mu-
tant sympathetic ganglia at aberrant loca-
tions (Fig. 6U, white arrowhead) and ap-
pearing to be more disorganized, the
proximal projectionswere often seen coursing along the intercos-
tal arteries similar to that in wild-type embryos (Fig. 6T,U, ar-
rows). The structural deficits observed inWnt5a/ sympathetic
chains is likely attributable to disruptions in elongation of the
Figure 6. Wnt5a/ mice show reduced innervation of SCG targets, enhanced apoptosis in the SCG, and abnormalities in
sympathetic chain formation.A–H, Tyrosine hydroxylase immunocytochemistry ofwild-type andWnt5a/ SCGat E13.5 (A,B),
E15.5 (C, D), E17.5 (E, F ), and P0.5 (G, H ). Scale bar, 100m. I, Quantification of SCG cell number in wild-type andWnt5a/
embryos at E13.5, E15.5, E17.5, and P0.5 byNissl staining and cell counting show that a significant reduction in cell number is first
evident in the mutants at E17.5 and progresses through P0.5. Values are the mean SEM (n 7 embryos for E13.5, n 5 for
E15.5, n 4 for E17.5, and n 3 for P0.5 for each genotype). **p 0.01 (E17.5) and *p 0.05 (P0.5) as determined by
unpaired, two-tailedStudent’s t test. J–M, Cleaved caspase-3 immunocytochemistry ofwild-typeandWnt5a/SCGat E15.5 (J,
K ) and E17.5 (L, M ). Scale bar, 100 m. N, Quantification of the percentage apoptotic cells in the SCG of wild-type and
Wnt5a/ embryos at E15.5 and E17.5 by counting the number of cleaved caspase-3-positive cells as a percentage of all tyrosine
hydroxylase-positive cells. Values are the mean SEM for each genotype (E15.5, n 5; E17.5, n 7). *p 0.0175 (E17.5) as
determined by an unpaired two-tailed Student’s t test. O, Quantification of percentage neuronal survival of dissociated sympa-
thetic neurons from E15.5 wild-type and Wnt5a/ SCG cultured in the presence of 1, 10, and 30 ng/ml NGF. Values are the
mean  SEM of four independent experiments. P, Q, Tyrosine hydroxylase immunocytochemistry and 4,6-diamidino-2-
phenylindole (DAPI) staining of the nasal epithelium in wild-type (P) andWnt5a/ (Q) E15.5 embryos reveals reduced inner-
vation in the absence ofWnt5a (tyrosine hydroxylase is shown in green and DAPI in blue). Scale bar, 50m. R, S, Whole-mount
tyrosine hydroxylase staining of the eye in wild-type (R) and Wnt5a/ (S) E16.5 mice indicates that SCG neurons fail to
innervate this target inWnt5a/ embryos (white arrows). Scale bar, 500m. T,U, Whole-mount tyrosine hydroxylase immu-
nostaining of E16.5 wild-type (T ) andWnt5a/ (U ) embryos show a disorganized sympathetic chain in the absence ofWnt5a
(black arrowheads indicate fused or ectopic ganglia; white arrowhead indicates abnormal axonal projections; black arrows indi-
cate proximal projections along intercostal arteries). Scale bar, 100m.
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anterior–posterior axis and integrity of the adjacent somites in
early embryonic development (Goldstein and Kalcheim, 1991;
Yamaguchi et al., 1999). Together, these results suggest that, al-
though reduced innervation of targets might be the result of def-
icits in the intrinsic abilities of Wnt5a/ axons to branch and
grow as seen in vitro, aberrant sympathetic chain formation and
navigational errors en route to distal targets could also potentially
contribute to the abnormalities in final target innervation ob-
served in vivo.
Wnt5a-mediated axonal branching requires PKC activity
locally in axons
Wnts signal through three major pathways: the canonical
-catenin-dependent pathway, the planar cell polarity (PCP)
pathway, and a Ca2-dependent pathway (Ciani and Salinas,
2005). Activation of the canonical Wnt signaling pathway stabi-
lizes the cytoplasmic effector, -catenin, which then translocates
to the nucleus and binds to the transcription factors T-cell factor
(TCF) and lymphoid enhancer factor (LEF) to activate the tran-
scription of target genes. Canonical Wnt pathway activity was
assessed in the developing SCG at E16.5, using TOPGAL trans-
genicmice in which LacZ expression reports-catenin transcrip-
tional activity (DasGupta and Fuchs, 1999). The SCG did not
show any X-gal staining for -galactosidase (Fig. 7A), whereas
prominent staining was seen in other tissues such as the cochlea
(supplemental Fig. 7, available at www.jneurosci.org as supple-
mental material) as previously reported (DasGupta and Fuchs,
1999). Interfering with the canonical Wnt signaling pathway by
expression of a dominant-negative inhibitor of the transcription
factor TCF in SCG explants had no effect on Wnt5a-dependent
axonal outgrowth (Fig. 7B–D). It must be noted here that
-catenin also signals via a transcription-independent mecha-
nism by complexing with cadherins and regulating cell adhesion
(Nelson and Nusse, 2004). Although we show that Wnt5a re-
sponses in sympathetic neurons are independent of -catenin-
mediated transcriptional activity, we cannot completely exclude
the role of -catenin in mediating Wnt5a responses.
Noncanonical Wnt signaling has been shown to elicit an in-
crease in intracellular Ca2 and activate Ca2-sensitive enzymes
such as CaMKII and PKC (Wodarz and Nusse, 1998; Veeman et
al., 2003; Kohn and Moon, 2005). In the Wnt–PCP pathway,
noncanonical Wnts activate the small GTPases Rho and Rac as
well as c-Jun N-terminal kinase (JNK) to regulate the uniform
orientation of cells within an epithelial plane, cellular migration,
and convergent-extension movements during neurulation
(Montcouquiol et al., 2006). To investigate the signaling path-
ways by which Wnt5a influences axonal branching, we used a
battery of phosphospecific antibodies to identify the signaling
effectors activated by Wnt5a in cultured sympathetic neurons.
Cultured sympathetic neurons stimulated with recombinant
Wnt5a (200 ng/ml; 30min) showed a significant increase in levels
of phosphorylated PKC, using a pan-phospho-PKC antibody
that recognizes endogenous PKC , I, II, , , , and  iso-
forms, when phosphorylated on Ser660 (Fig. 7E). Levels of phos-
Figure 7. Wnt5a mediates branching via protein kinase C. A, Canonical Wnt/-catenin signaling in TOPGAL reporter transgenic mouse line is not detected in E16.5 SCG (outlined with dashed
line); the asterisk (*) identifies a neighboring blood vessel. Scale bar, 100m.B, C, TCF transcriptional activity is not required forWnt5a-mediated axon outgrowth. SCG explants infectedwith GFP
(B) or dominant-negative-TCF (dn-TCF) (C) adenovirus show robust neurite outgrowth in response to Wnt5a. Ganglia were immunostained for-III-tubulin. Scale bar, 320m. D, Quantification
of neurite outgrowth from SCG explants infected with either GFP or dn-TCF in the presence or absence of Wnt5a-containing media. Values are the mean SEM for four explants. No significant
difference in neurite outgrowth was observed between Wnt5a-treated explants infected with either GFP or dn-TCF adenovirus. Wnt5a-treated explants infected with GFP or dn-TCF were
significantly different from control conditioned media-treated explants; **p 0.01 and ***p 0.001, as determined by one-way ANOVA followed by Tukey’s multiple-comparisons test. E,
Cultured sympathetic neurons stimulated with recombinant Wnt5a (200 ng/ml; 30 min) show increased levels of phosphorylated PKC (p-PKC). In contrast, levels of p-GSK3, p-c-Jun, p-CaMKII,
were unaffected. All Western blots were stripped and reprobed for the p85 subunit of PI3-K as a loading control. F, G, Wnt5a-dependent axonal branching in sympathetic neurons requires PKC
activity. Sympathetic neurons cultured for 24h in thepresence ofWnt5a showextensive branching (F ) that is abrogatedby treatmentwith amyristoylatedPKCpseudosubstrate (G). Neuronswere
immunostained for-III-tubulin. Scale bar, 50m. H, I, Quantification of branch points per neuron (H ) and neurite length (I ) in low-density dissociated cultures treated with control or Wnt5a
conditioned media, in the presence or absence of PKC-pseudosubstrate. Values are the mean SEM from three independent experiments. ***p 0.001 significantly different from control
conditionedmedia-treated neurons, as determined by one-way ANOVA followed by Tukey’smultiple-comparisons test. J, Quantification of newbranch points per projection per 24 h in low-density
compartmentalized cultures treated with control or Wnt5a-containing media exclusively on distal axons (DA), in the absence or presence of PKC-pseudosubstrate added to DA or cell bodies
compartments (CB). Values are the mean SEM from three independent experiments. **p 0.01, significantly different from control conditioned media-treated neurons, as determined by
one-way ANOVA followed by Tukey’s multiple-comparisons test. PKC (DA) is significantly different from PKC (CB), p 0.05.
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phorylatedGSK-3, a component in the canonicalWnt signaling
pathway, phosphorylated c-jun, a component of the JNK signal-
ing pathway, and phosphorylated CaMKII were unaffected by
Wnt5a treatment (Fig. 7E). Additionally, Wnt5a treatment did
not elicit any changes in the twomajor signaling pathways known
to be activated byNGF, as evidenced by equivalent levels of phos-
phorylated Akt and Erk1/2 in control and Wnt5a-treated neu-
rons (supplemental Fig. 6, available at www.jneurosci.org as sup-
plemental material).
Given the Wnt5a-induced increase in phosphorylated PKC,
we asked whether PKC is required for Wnt5a-mediated axonal
branching in sympathetic neurons. To inhibit PKC activity, we
used myristoylated PKC pseudosubstrate (25 M), a cell-
permeable peptide that blocks PKC activity by preventing sub-
strate binding (Eichholtz et al., 1993; Wolf et al., 2008). PKC
inhibition effectively repressed Wnt5a-induced branching (Fig.
7F–H) without affecting neurite length in control and Wnt5a-
treated neurons (Fig. 7I). Furthermore, by spatially inhibiting
PKC activity in the distal axons or cell bodies of compartmental-
ized cultures, we found that Wnt5a-induced axon branching re-
quires local PKC signaling in distal axons (Fig. 7J). Together, our
results indicate that Wnt5a-mediated axon remodeling in sym-
pathetic neurons requires PKC activity locally in axons.
Discussion
The family of neurotrophins provides one of the best examples of
target-derived instructive cues that regulate multiple facets of
neuronal development including cell survival, axonal and den-
dritic growth, and synapse formation. Our study highlights a
previously uncharacterized regulatory pathway in which target-
derived NGF promotes axonal branching and target innervation
during sympathetic neuron development by enhancing neuronal
expression ofWnt5a.We found thatWnt5a is highly expressed in
sympathetic neurons at a developmental time when their axons
are reaching and innervating final target tissues. Wnt5a expres-
sion is enhanced by NGF, but not by NT-3, an intermediate
target-derived axon growth factor for sympathetic neurons.
Wnt5a exerts a rapid effect on promoting axon branching and a
more delayed effect on enhancing extension. Sympathetic neu-
rons derived from Wnt5a/ mice show deficits in NGF-
dependent axonal branching and growth, but not survival, in
vitro. In the absence of Wnt5a, sympathetic innervation of final
target tissues is absent or highly attenuated at early stages preced-
ing increased neuronal apoptosis. These findings revealWnt5a as
a novel NGF effector that regulates axonal growth, branching,
and innervation of sympathetic target tissues. Our study adds to
emerging evidence that mechanisms of cross talk between target-
derived neurotrophins and growth factors expressed in neurons
could underlie neurotrophin actions in the nervous system. In a
recent study, autocrine signaling of glucocorticoid-induced tu-
mor necrosis factor receptor-related protein (GITR) and its li-
gand GITRL within developing sympathetic neurons was shown
to be essential for target-derived NGF to promote axon growth
and target innervation (O’Keeffe et al., 2008).
Our results indicate that the aspect ofNGF-dependent growth
most sensitive to Wnt5a signaling is axonal branching. In the
presence of NGF, sympathetic neurons lackingWnt5a show sig-
nificantly reduced axonal branching both in vitro and in vivo.
Within minutes of Wnt5a treatment, axons of sympathetic neu-
rons show distinct branching of growth cones, sprouting of pro-
cesses from the growth cones, and extension of these new
branches. Within 2 h of Wnt5a addition, axons develop complex
arborization patterns, whereas a significant effect on axon exten-
sion was only observed after extended periods of growth (3 d) in
the presence of theWnt ligand. In vivo, an acute effect ofWnt5a in
sympathetic axons might be to initiate axonal branching on ax-
ons reaching final targets, whereas a delayed effect of Wnt5a
might be to promote extension of the newly formed branches to
completely cover the target territory.
We demonstrated that Wnt5a/ neurons show profound
deficits in axon branching and growth in vitro. There is no cell-
autonomous requirement for Wnt5a in mediating neuronal sur-
vival, and yet enhanced cell death in vivo is observed inWnt5a/
SCGs at times when axons are actively innervating target tissues.
There are no statistically significant differences in SCG cell num-
ber between wild-type and Wnt5a/ embryos at E13.5–E15.5,
before, or at very early stages of, target innervation. Since most
neurogenesis in mouse SCG is complete by E15.5 and the major
period of gliogenesis occurs postnatally (Fagan et al., 1996), the
normal SCG cell number at E15.5 suggests that proliferation and
survival of neuronal precursors are unaffected by the absence of
Wnt5a. However, at E17.5, there is a significant increase in cell
loss and apoptosis, similar to the phenotype observed inNGF/
and TrkA/ mice, suggesting that, in the absence of Wnt5a,
axons are unable to reach final targets and gain access to NGF. In
support of this hypothesis, distal target tissues such as the nasal
epithelium and eye show far less sympathetic fibers at the earliest
stages (E15.5–E16.5) of final target innervation, preceding signif-
icant cell loss. In light of our in vitro data showing that Wnt5a is
required in dissociated sympathetic neurons for NGF-mediated
axon branching and growth, we propose that the most parsimo-
nious explanation for reduced innervation seen in vivo is an in-
trinsic inability ofWnt5a/ axons to grow and branch into final
targets. We also observed deficits in sympathetic chain segmen-
tation in Wnt5a-deficient embryos. Segmentation defects may
arise, in part, from the reported disruptions in the rostrocaudal
integrity of the adjacent somites in the embryonic Wnt5a-null
mice (Yamaguchi et al., 1999). The rostral somites are normal in
E9.5 Wnt5a mutants, whereas the caudal somites become pro-
gressively smaller in size (Yamaguchi et al., 1999). We observed a
similar rostral–caudal decline in the integrity of the sympathetic
chain ganglia inWnt5a/ embryos. Thus, the SCG, the rostral-
most ganglia in the sympathetic chain, appeared to be normally
located at the bifurcation of the carotid artery, and of normal size
until E15.5, and it seems less likely that the reduced innervation of
distal SCG targets arises primarily from disruptions in the sym-
pathetic chain. However, we cannot completely exclude the pos-
sibilities that defects in somite integrity in Wnt5a/ embryos
and subsequent effects on sympathetic chain segmentation or
non-cell-autonomous roles for Wnt5a in intermediate target tis-
sues lead to navigational deficits that contribute, at least in part,
to decreased final target innervation.
The localized effects of Wnt5a in axons combined with the
result thatWnt5a-dependent axon branching is transcription in-
dependent suggest a direct modulation of the actin–microtubule
cytoskeleton in axons. Recently, Wnt3a was shown to mediate
rapid changes in microtubule organization and directionality in
developing DRG neurons, promoting growth cone pausing, ex-
pansion, and branching (Purro et al., 2008). Our results indicate
that regulation of classical PKCs that are sensitive to elevations in
intracellular Ca2 and diacylglycerol might underlie the actions
of Wnt5a in sympathetic axons. Interestingly, Wnt5a induces
extensive remodeling of the actin cytoskeletal architecture to pro-
mote directionalmotility and invasiveness ofmelanoma cells by a
-catenin-independent mechanism that involves phosphoryla-
tion and activation of classical PKCs (Weeraratna et al., 2002;
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Witze et al., 2008). Given the ability of PKCs to activate multiple
signaling effectors including known regulators of axonmorphol-
ogy such as FAK (focal adhesion kinase) (Cohen et al., 2002; Rico
et al., 2004) and GAP-43 (Aigner et al., 1995; He et al., 1997),
additional studies are required to shed light on local PKC effec-
tors in axons that contribute to axonal branching. However, con-
sistent with our observations of a local requirement for PKC
activity in sympathetic axons in regulating branching, a previous
study in compartmentalized cultures demonstrated that NGF-
dependent axon growth is attenuated by inhibition of PKC activ-
ity in distal neurites but not cell bodies (Campenot et al., 1994).
Although much is known about Wnt signaling, our current
knowledge of the regulation ofWnt genes themselves is very lim-
ited. We propose that NGF secreted by target tissues signals ret-
rogradely to sympathetic nuclei to ensure precise spatial and tem-
poral control of Wnt5a expression during target innervation. In
vivo studies indicate that retrogradeNGF signaling activates tran-
scriptional programs essential for long-term changes in axon
growth through the nuclear effectors, cyclic adenosine mono-
phosphate element-binding protein (CREB), nuclear factor of
activated T-cells (NFAT), and serum response factor (SRF)
(Lonze andGinty, 2002; Graef et al., 2003;Wickramasinghe et al.,
2008). Conditional deletion of SRF in NGF-responsive sensory
neurons revealed a specific requirement for SRF in axonal ar-
borization during the final phase of target innervation (Wickra-
masinghe et al., 2008). Interestingly, a consensus SRF binding
site, the CArG-like sequence is present in a 1 kb region upstream
of the transcriptional start site of Wnt5a. Expression of a
dominant-negative form of SRF, but not dominant-negative in-
hibitors of CREB and NFAT, substantially attenuatedWnt5a lev-
els in cultured sympathetic neurons maintained in the presence
of NGF (D. Bodmer and R. Kuruvilla, unpublished observa-
tions). Together, these results allude to an SRF-dependentmech-
anism of Wnt5a expression in developing sympathetic neurons,
although additional studies are warranted to test this hypothesis.
Our results demonstrate a critical role for Wnt5a signaling
within sympathetic neurons to mediate branching; however, this
does not preclude an additive role for Wnts secreted by target
tissues themselves in mediating terminal arborization. RT-PCR
analyses showed that Wnt5a is present in the SCG target tissues,
salivary glands and trachea (data not shown). In a recent study,
BDNF signaling in cerebellar granule cell precursors was shown
to cooperate with exogenous BDNF to amplify a local BDNF
gradient and thus direct migration of cerebellar granule cell pre-
cursors (Zhou et al., 2007). In an analogous manner, Wnt5a se-
creted by sympathetic axons might act in concert with target-
derived Wnt5a to amplify axonal responses within target tissues.
Our study raises the possibility that other neurotrophin-
dependent processes in the developing nervous system might be
mediated in a similar manner through a hierarchical trophic fac-
tor cascade. In particular, both neurotrophins and Wnts have
been shown to be potent synaptogenic factors (Vicario-Abejo´n et
al., 2002; Speese and Budnik, 2007); it remains to be determined
whether neurotrophins promote synapse formation by regulat-
ing the expression and signaling of Wnts. Uncovering mecha-
nisms of cross talk between neurotrophins and other signaling
pathways will provide new insight into how a relatively small
number of growth factors can be used to assemble complex, yet
precise, neuronal circuits during development.
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